Syngene International

Syngene International Current Assets

The Current Assets of Syngene International (SYNGENE.NS) as of Oct 31, 2026 is 16.34 B INR. In the previous year, Current Assets was 23.91 B INR — a change of -31.67% (lower).

Current Assets

16.34 BINR

YoY

-31.67%

Last updated:

Current Assets of Syngene International is 2026 16.34 B INR. Current Assets of Syngene International was 2025 23.91 B INR. It decreases by -31.67% lower compared to the previous year.

The Syngene International Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2019
17.68 B INR
Jan 1, 2020
16.30 B INR
Jan 1, 2021
18.38 B INR
Jan 1, 2022
22.86 B INR
Jan 1, 2023
25.00 B INR
Jan 1, 2024
20.55 B INR
Jan 1, 2025
23.91 B INR
Jan 1, 2026
16.34 B INR
The Syngene International Current Assets history
YEARCurrent AssetsYoY
16.34 BINR-31.67%
23.91 BINR+16.38%
20.55 BINR-17.81%
25.00 BINR+9.36%
22.86 BINR+24.35%
18.38 BINR+12.75%
16.30 BINR-7.78%
17.68 BINR-16.64%
21.21 BINR+50.64%
14.08 BINR+7.42%
13.11 BINR+115.15%
6.09 BINR-5.32%
6.43 BINR+206.38%
2.10 BINR+93.19%
1.09 BINR+69.84%
640.00 MINR-9.73%
709.00 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Syngene International Stock analysis

What does Syngene International do? Syngene International Ltd. was founded in Bangalore, India in 1993 and specializes in the development and manufacturing of pharmaceuticals, as well as biotechnology services. It is a global contract research organization and part of the Biocon Group, a leading biotech company based in India. Syngene's business model is based on collaborations with global customers in the pharmaceutical, biotech, and agrochemical industries. The company offers a wide range of services including research and development, preclinical development, active pharmaceutical ingredients manufacturing, formulation development, clinical development, and commercial manufacturing. Syngene operates in various divisions, including research and development, formulation development, preclinical services, clinical development, and manufacturing of active pharmaceutical ingredients and formulations. It has multiple locations, including research centers in Hyderabad, Chennai, and Pune, in addition to its headquarters in Bangalore. The company is known for its innovative and socially responsible practices, and has received several awards and recognitions, including the Golden Peacock Award for Corporate Social Responsibility in 2018 and the Best Indian CRO Award at the Global Pharma Excellence Awards in 2019. Syngene aims to establish itself as a global leader in biotech and pharmaceutical discovery and development services, with a focus on customer satisfaction and employee experience. It has become a trusted partner for clients in the pharmaceutical, biotech, and agrochemical industries, offering a wide range of services to support drug and biotech product development. Overall, Syngene International Ltd. is a key player in the contract research and development market, providing comprehensive services to support the development and manufacturing of pharmaceutical and biotechnology products. Syngene International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Syngene International stock

Current Assets of Syngene International is 16.34 B INR in 2026.

Current Assets of Syngene International changed from 23.91 B INR to 16.34 B INR, representing a -31.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Syngene International since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Syngene International historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Syngene International

All Key Metrics — Syngene International